Optimizing Apheresis Logistics: Frozen vs. Fresh – A Critical Evaluation for Cell Therapy Manufacturing
Time: 4:45 pm
day: Conference Day One
Details:
- Logistical Considerations: Examining the operational challenges and complexities involved in transporting and storing frozen versus fresh apheresis materials
- Quality Control & Processing Impact: How the choice between frozen and fresh apheresis impacts cell viability, processing efficiency, and product quality
- Leveraging Benefits for Scalable Manufacturing: Identifying the advantages and limitations of both options to determine the most effective strategy for large-scale, reproducible cell therapy production
